MS Awareness Week continues through Sunday - KCBD NewsChannel 11 Lubbock

3/9/10

MS Awareness Week continues through Sunday

Posted:
LUBBOCK, TX (KCBD) -

By Ben Lawson  - bio | email

LUBBOCK, TX (KCBD) - This week you're asked to join the movement to end Multiple Sclerosis (MS), and new research is bringing new hope to MS patients. It is MS Awareness Week, and this year some are looking forward to the possibility of treating the disease without shots.

The National MS Society reports someone is diagnosed with MS every hour of every day.  With MS the body's own defense system attacks the protective coating around nerve fibers in the central nervous system. The nerves themselves can also be damaged.

The damaged coating forms scar tissue, called Sclerosis, which gives the disease its name. When that happens, impulses traveling to and from the brain and spinal cord are distorted or interrupted, causing symptoms.

Doctors say awareness and continued research is vital in the fight against MS. Right now, shots to suppress the immune system are the only way to treat the disease, but advancing research may soon allow patients to be treated with a pill.

"We are hoping this can be a great help to us, especially for the patient who's not compliant with the injections as far as treatment," Dr. Ahmad Sabouni said.  Right now the FDA is still testing the pills and other options are also in development.

Meanwhile, the West Texas chapter of the MS Society will host their fundraising walk next month on the Texas Tech University campus(Click Here) for more information on the walk. 

(Click Here) for more information on Multiple Sclerosis from the National MS Society.

©2010 KCBD NewsChannel 11. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Powered by WorldNow

5600 Avenue A
Lubbock, TX. 79404

FCC Public File
publicfile@kcbd.com
806-744-1414
EEO Report
Closed Captioning

All content © Copyright 2000 - 2014 Worldnow and KCBD. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.